The E3 Ubiquitin Ligase Mindbomb1 controls planar cell polarity-dependent convergent extension movements during zebrafish gastrulation

Abstract

Vertebrate Delta/Notch signaling involves multiple ligands, receptors and transcription factors. Delta endocytosis - a critical event for Notch activation - is however essentially controlled by the E3 Ubiquitin ligase Mindbomb1 (Mib1). Mib1 inactivation is therefore often used to inhibit Notch signaling. However, recent findings indicate that Mib1 function extends beyond the Notch pathway. We report a novel Notch-independent role of Mib1 in zebrafish gastrulation. mib1 null mutants and morphants display impaired Convergence Extension (CE) movements. Comparison of different mib1 mutants and functional rescue experiments indicate that Mib1 controls CE independently of Notch. Mib1-dependent CE defects can be rescued using the Planar Cell Polarity (PCP) downstream mediator RhoA, or enhanced through knock-down of the PCP ligand Wnt5b. Mib1 regulates CE through its RING Finger domains that have been implicated in substrate ubiquitination, suggesting that Mib1 may control PCP protein trafficking. Accordingly, we show that Mib1 controls the endocytosis of the PCP component Ryk and that Ryk internalization is required for CE. Numerous morphogenetic processes involve both Notch and PCP signaling. Our observation that during zebrafish gastrulation Mib1 exerts a Notch-independent control of PCP-dependent CE movements suggest that Mib1 loss of function phenotypes should be cautiously interpreted depending on the biological context.

Data availability

All data generated or analysed during this study are included in the manuscript.

Article and author information

Author details

  1. Vishnu Muraleedharan Saraswathy

    Université Côte d'Azur, CNRS, Inserm, iBV, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Akshai Janardhana Kurup

    Université Côte d'Azur, CNRS, Inserm, iBV, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Priyanka Sharma

    Université Côte d'Azur, CNRS, Inserm, iBV, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Sophie Polès

    Université Côte d'Azur, CNRS, Inserm, iBV, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Morgane Poulain

    Université Côte d'Azur, CNRS, Inserm, iBV, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Maximilian Fürthauer

    Université Côte d'Azur, CNRS, Inserm, iBV, Nice, France
    For correspondence
    furthauer@unice.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6344-6585

Funding

Fondation ARC pour la Recherche sur le Cancer (PJA20181208167)

  • Maximilian Fürthauer

Agence Nationale de la Recherche (ANR-17-CE13-0024-02)

  • Maximilian Fürthauer

Agence Nationale de la Recherche (ANR-11-LABX-0028-01)

  • Vishnu Muraleedharan Saraswathy

Ligue Contre le Cancer (IP/SC-17131)

  • Akshai Janardhana Kurup

Fondation pour la Recherche Médicale (FDT20140930987)

  • Priyanka Sharma

Human Frontier Science Program (CDA00036/2010)

  • Maximilian Fürthauer

Centre National de la Recherche Scientifique (ATIP2010)

  • Maximilian Fürthauer

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Ajay Chitnis

Ethics

Animal experimentation: Animal experiments were performed in the iBV Zebrafish facility (authorization #B-06-088-17) in accordance with the guidelines of the ethics committee Ciepal Azur and the iBV animal welfare committee (project authorizations NCE/2013-92, 19944-2019031818528380).

Version history

  1. Preprint posted: July 5, 2021 (view preprint)
  2. Received: July 5, 2021
  3. Accepted: February 9, 2022
  4. Accepted Manuscript published: February 10, 2022 (version 1)
  5. Version of Record published: March 21, 2022 (version 2)

Copyright

© 2022, Saraswathy et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,223
    views
  • 205
    downloads
  • 3
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Vishnu Muraleedharan Saraswathy
  2. Akshai Janardhana Kurup
  3. Priyanka Sharma
  4. Sophie Polès
  5. Morgane Poulain
  6. Maximilian Fürthauer
(2022)
The E3 Ubiquitin Ligase Mindbomb1 controls planar cell polarity-dependent convergent extension movements during zebrafish gastrulation
eLife 11:e71928.
https://doi.org/10.7554/eLife.71928

Share this article

https://doi.org/10.7554/eLife.71928

Further reading

    1. Developmental Biology
    2. Structural Biology and Molecular Biophysics
    Samuel C Griffiths, Jia Tan ... Hsin-Yi Henry Ho
    Research Article Updated

    The receptor tyrosine kinase ROR2 mediates noncanonical WNT5A signaling to orchestrate tissue morphogenetic processes, and dysfunction of the pathway causes Robinow syndrome, brachydactyly B, and metastatic diseases. The domain(s) and mechanisms required for ROR2 function, however, remain unclear. We solved the crystal structure of the extracellular cysteine-rich (CRD) and Kringle (Kr) domains of ROR2 and found that, unlike other CRDs, the ROR2 CRD lacks the signature hydrophobic pocket that binds lipids/lipid-modified proteins, such as WNTs, suggesting a novel mechanism of ligand reception. Functionally, we showed that the ROR2 CRD, but not other domains, is required and minimally sufficient to promote WNT5A signaling, and Robinow mutations in the CRD and the adjacent Kr impair ROR2 secretion and function. Moreover, using function-activating and -perturbing antibodies against the Frizzled (FZ) family of WNT receptors, we demonstrate the involvement of FZ in WNT5A-ROR signaling. Thus, ROR2 acts via its CRD to potentiate the function of a receptor super-complex that includes FZ to transduce WNT5A signals.

    1. Cell Biology
    2. Developmental Biology
    Nicolas Loyer, Elizabeth KJ Hogg ... Jens Januschke
    Research Article Updated

    The generation of distinct cell fates during development depends on asymmetric cell division of progenitor cells. In the central and peripheral nervous system of Drosophila, progenitor cells respectively called neuroblasts or sensory organ precursors use PAR polarity during mitosis to control cell fate determination in their daughter cells. How polarity and the cell cycle are coupled, and how the cell cycle machinery regulates PAR protein function and cell fate determination is poorly understood. Here, we generate an analog sensitive allele of CDK1 and reveal that its partial inhibition weakens but does not abolish apical polarity in embryonic and larval neuroblasts and leads to defects in polarisation of fate determinants. We describe a novel in vivo phosphorylation of Bazooka, the Drosophila homolog of PAR-3, on Serine180, a consensus CDK phosphorylation site. In some tissular contexts, phosphorylation of Serine180 occurs in asymmetrically dividing cells but not in their symmetrically dividing neighbours. In neuroblasts, Serine180 phosphomutants disrupt the timing of basal polarisation. Serine180 phosphomutants also affect the specification and binary cell fate determination of sensory organ precursors as well as Baz localisation during their asymmetric cell divisions. Finally, we show that CDK1 phosphorylates Serine-S180 and an equivalent Serine on human PAR-3 in vitro.